Abbvie CDR (Cad Hedged) (ABBV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2,079,000 | 2,131,000 | 2,074,000 | 2,076,000 | 2,235,000 |
| Income taxes - deferred | -277,000 | -16,000 | -389,000 | -1,391,000 | -863,000 |
| Accounts receivable | 344,000 | 178,000 | -702,000 | 339,000 | 2,000 |
| Accounts payable and accrued liabilities | 267,000 | -1,699,000 | 362,000 | 179,000 | 2,554,000 |
| Other Working Capital | 750,000 | -3,382,000 | 247,000 | 443,000 | 2,643,000 |
| Other Operating Activity | 2,284,000 | 5,059,000 | 2,448,000 | 3,107,000 | 1,003,000 |
| Operating Cash Flow | $5,447,000 | $2,271,000 | $4,040,000 | $4,753,000 | $7,574,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -249,000 | -241,000 | -193,000 | -205,000 | -219,000 |
| Net Acquisitions | -8,493,000 | -843,000 | -9,389,000 | -553,000 | -157,000 |
| Purchase Of Investment | -24,000 | -16,000 | -6,000 | -34,000 | -8,000 |
| Sale Of Investment | 507,000 | 3,000 | 6,000 | 14,000 | 5,000 |
| Other Investing Activity | 3,000 | -5,000 | -6,000 | -22,000 | 10,000 |
| Investing Cash Flow | $-8,256,000 | $-1,102,000 | $-9,588,000 | $-800,000 | $-369,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | -3,000 | 3,000 | N/A | N/A |
| Debt Issued | 0 | 0 | 14,963,000 | 0 | 0 |
| Debt Repayment | -403,000 | -3,345,000 | -103,000 | -1,794,000 | -2,000 |
| Common Stock Repurchased | -17,000 | -9,000 | -1,324,000 | -3,000 | -4,000 |
| Dividend Paid | -2,751,000 | -2,750,000 | -2,772,000 | -2,626,000 | -2,627,000 |
| Other Financing Activity | 99,000 | 10,000 | 52,000 | -26,000 | -28,000 |
| Financing Cash Flow | $-3,072,000 | $-6,097,000 | $10,819,000 | $-4,449,000 | $-2,661,000 |
| Exchange Rate Effect | 8,000 | -9,000 | -18,000 | 23,000 | -16,000 |
| Beginning Cash Position | 13,130,000 | 18,067,000 | 12,814,000 | 13,287,000 | 8,759,000 |
| End Cash Position | 7,257,000 | 13,130,000 | 18,067,000 | 12,814,000 | 13,287,000 |
| Net Cash Flow | $-5,881,000 | $-4,928,000 | $5,271,000 | $-496,000 | $4,544,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,447,000 | 2,271,000 | 4,040,000 | 4,753,000 | 7,574,000 |
| Capital Expenditure | -249,000 | -241,000 | -193,000 | -205,000 | -219,000 |
| Free Cash Flow | 5,198,000 | 2,030,000 | 3,847,000 | 4,548,000 | 7,355,000 |